[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:classic-congenital-adrenal-hyperplasia":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":22,"states":23},"Classic Congenital Adrenal Hyperplasia",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06712823","An Extension Study to Evaluate Safety and Efficacy of Atumelnant in Participants With Congenital Adrenal Hyperplasia",[11],"Phase 2","RECRUITING","2026-08-26T02:17:26.640202Z","2026-07-05T03:45:20.454869Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT07159841","A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)",[19],"Phase 2\u002FPhase 3","2026-08-26T02:18:54.586325Z","2026-06-16T05:54:07.932993Z",[],[]]